Home > PJ (current issue) > Reviews | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7443 p323
17 March 2007

Reviews (books)

Comprehensive and fascinating insight into the development of the pharmaceutical industry

The law and ethics of the pharmaceutical industry’, by Graham Dukes. Pp xvii+409. Price £29.95. London: Elsevier Ltd; 2006. ISBN 0 444 51868 1


This book comprises 12 chapters about the pharmaceutical industry’s relationship with communities and commerce. The author is not afraid to express his personal views on the major effect trans-national pharmaceutical companies exert, within industrial societies and in developing countries, on the health, economic and political processes. He adds his own comments and suggestions for change.

He outlines clearly the development of the industry from the Middle Ages via charlatans, through apothecaries, to the sophisticated present of legislation and ethics. There is a useful section on law dealing with, among others, counterfeiting, patent protection and the TRIPS agreement. On these, the author expresses his personal views together with describing aspects of corporate social responsibility and government. He discusses the role of the industry in the community both professionally and commercially, the growing need for honesty and integrity and the pressures brought upon the industry by its globalisation and activists such as international charities.

He expresses concern about the ethics of the industry and the control by professionals, particularly medical directors, and the potential role of pharmacists. There is an interesting section on standards and ethics that covers confidentiality, duty of care, integrity and honesty in the industry. This is a comprehensive and fascinating insight into the development of the pharmaceutical industry. Many pharmacists will find it readable and informative and I recommend it to industrial pharmacists particularly and those at the top of the industry.


Gordon Appelbe
(an independent pharmaceutical and legal consultant and former head of the Royal Pharmaceutical Society’s law department)

Back to Top


©The Pharmaceutical Journal